PD-1 Blockade Alone Versus in Combination With Chemotherapy as First Line Therapy in Females With Advanced NSCLC & PD-L1 Expression ≥50%

​ Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: Pembrolizumab; Drug: Carboplatin (AUC 5); Drug: Cisplatin (75 mg/m²); Drug: Pemetrexed (500 mg/m²); Drug: nab-Paclitaxel (100 mg/m² )

Sponsors: German Cancer Research Center

Not yet recruiting Conditions: Non-Small Cell Lung Cancer
Interventions: Drug: Pembrolizumab; Drug: Carboplatin (AUC 5); Drug: Cisplatin (75 mg/m²); Drug: Pemetrexed (500 mg/m²); Drug: nab-Paclitaxel (100 mg/m² )
Sponsors: German Cancer Research Center
Not yet recruiting